Closed
Funding for Company-driven RNA Innovation (AReNA)
Supports company-driven RNA innovation
Last Update: April 29, 2026
Funding available
Varies by project
Timeline
- Closing date : March 30, 2026
Location
Quebec, Canada
Overview
This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop a new product or service
- Conduct research and development activities
- Launch or market a product/service
Eligible Funding
- Varies by project
Timeline
- Closing date : March 30, 2026
Eligible candidates
Eligible Industries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
Location
- Quebec
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Development of innovative technologies for the RNA therapy sector.
- Commercialization of Québec biopharmaceutical innovations.
Eligibility
Eligible geographic areas
- Quebec
Processing and Agreement
- A non-selective letter of intent is submitted first.
- Complete applications are then submitted for review.
- Applications are sent by email to appliquez-apply@cqdm.org.
Additional information
- The program is funded by the Ministry of Economy, Innovation and Energy (MEIE).
- It is managed by CQDM as part of AReNA, Québec’s RNA Hub.
- Applicants are directed to the AReNA website for full program details.
Contacts
Frequently Asked Questions about the Funding for Company-driven RNA Innovation (AReNA) Program
Here are answers to the most common questions about the Funding for Company-driven RNA Innovation (AReNA). This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Funding for Company-driven RNA Innovation (AReNA)?
This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.
What expenses are eligible under Funding for Company-driven RNA Innovation (AReNA)?
Development of innovative technologies for the RNA therapy sector.
Commercialization of Québec biopharmaceutical innovations.
Who can I contact for more information about the Funding for Company-driven RNA Innovation (AReNA)?
You can contact Quebec Consortium for Drug Discovery (CQDM) by email at appliquez-apply@cqdm.org.
Where is the Funding for Company-driven RNA Innovation (AReNA) available?
The Funding for Company-driven RNA Innovation (AReNA) program is available the province of Quebec.
Is the Funding for Company-driven RNA Innovation (AReNA) a grant, loan, or tax credit?
Funding for Company-driven RNA Innovation (AReNA) is a Other Support
Who are the financial supporters of the Funding for Company-driven RNA Innovation (AReNA)?
Funding for Company-driven RNA Innovation (AReNA) is funded by Quebec Consortium for Drug Discovery (CQDM)